CAS 1799802-29-1

4-Morpholinepropanamide, N-[5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-3-[(ethylamino)carbonyl]-4-isoxazolyl]-, hydrochloride (1:1)

Description:

4-Morpholinepropanamide, N-[5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-3-[(ethylamino)carbonyl]-4-isoxazolyl]-, hydrochloride (1:1) is a complex organic compound characterized by its unique structural features, including a morpholine ring and an isoxazole moiety. This compound exhibits properties typical of amides, such as potential solubility in polar solvents and the ability to form hydrogen bonds due to the presence of hydroxyl groups. The presence of the ethylamino group suggests that it may have basic characteristics, which could influence its interaction with biological systems. The hydrochloride form indicates that it is a salt, which often enhances solubility in aqueous environments. This compound may be of interest in pharmaceutical research, particularly for its potential biological activity, given the presence of functional groups that can participate in various chemical interactions. Its specific applications and efficacy would depend on further studies, including pharmacokinetics and pharmacodynamics, to elucidate its behavior in biological systems.

Formula: C₂₂H₃₀N₄O₆·ClH

Synonyms:

• 4-Morpholinepropanamide, N-[5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-3-[(ethylamino)carbonyl]-4-isoxazolyl]-, hydrochloride (1:1)

SST0116CL1

CAS: 1799802-29-1

SST0116CL1 is an HSP90 inhibitor (IC50: 0.21 μM) that targets the ATP-binding pocket of Hsp90, disrupting its chaperone function and leading to the degradation of client proteins (EGFR, CDK4, and AKT). It induces the degradation of Her2 in BT-474 cells (IC50: 0.2 μM) and exhibits antiproliferative activity, inhibiting tumor growth.

Formula: C₂₂H₃₁ClN₄O₆

Color and Shape: Solid

Molecular weight: 482.96

Ref: TM-T200022